Kewaunee Scientific Corporation (NASDAQ:KEQU) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of KEQU, it is a notable dividend-paying company that has been able to sustain great financial health over the past. Below is a brief commentary on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Kewaunee Scientific here.
Flawless balance sheet average dividend payer
KEQU’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This implies that KEQU manages its cash and cost levels well, which is an important determinant of the company’s health. KEQU seems to have put its debt to good use, generating operating cash levels of 0.69x total debt in the most recent year. This is also a good indication as to whether debt is properly covered by the company’s cash flows.
KEQU is also a dividend company, with ample net income to cover its dividend payout, which has been consistently growing over the past decade, keeping income investors happy.
For Kewaunee Scientific, I’ve put together three important aspects you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for KEQU’s future growth? Take a look at our free research report of analyst consensus for KEQU’s outlook.
- Historical Performance: What has KEQU’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of KEQU? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.